| Indicator | This Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥139.8B | ¥146.0B | -4.3% |
| Operating Income / Operating Profit | ¥3.5B | ¥7.0B | -50.0% |
| Ordinary Income | ¥4.1B | ¥6.2B | -34.5% |
| Net Income / Net Profit | ¥7.2B | ¥4.0B | +82.6% |
| ROE | 3.6% | 2.1% | - |
For FY2027 ending March, Q1 Revenue was ¥139.8B (YoY -¥6.2B -4.3%), Operating Income ¥3.5B (YoY -¥3.5B -50.0%), Ordinary Income ¥4.1B (YoY -¥2.1B -34.5%), Net Income ¥7.2B (YoY +¥3.3B +82.6%). Revenue declined year-on-year, Operating Income fell significantly, while Net Income rose substantially due to the recording of ¥8.8B in special gains (primarily compensation income of ¥8.8B). Operating margin deteriorated to 2.5% (down 2.3pt from 4.8% a year earlier). SG&A ratio increased to 18.5% (up 2.6pt from 15.9%), offsetting an improvement in gross margin (21.0%, up 0.3pt from 20.7%). The increase in bottom-line profit depends on a one-off item; core earnings power has weakened.
[Revenue] Revenue of ¥139.8B was down 4.3% YoY. By segment, the core Manufacturing Business recorded ¥112.4B (YoY -8.2%, sales mix 80.4%) with a large decline, the Sales Business grew to ¥28.7B (YoY +15.2%, mix 20.5%), and Other Businesses rose to ¥1.3B (YoY +90.2%) though remaining small. By geography, Japan declined to ¥103.9B (prior ¥120.1B), Singapore increased to ¥26.9B (prior ¥21.5B), and Other Overseas expanded to ¥8.4B (prior ¥3.9B). Slowing sales in the domestic market for the Manufacturing Business was the main driver of the company's overall revenue decline; growth in the Sales Business did not fully offset this.
[Profitability] Operating Income of ¥3.5B represented a large YoY decline of 50.0%. Cost of goods sold was ¥110.4B (cost of sales ratio 79.0%), yielding gross profit of ¥29.4B (gross margin 21.0%), but SG&A of ¥25.9B (SG&A ratio 18.5%) increased by 11.5% YoY, significantly weakening operating-level profitability. By segment, Manufacturing Business Operating Income was ¥5.0B (prior ¥9.0B, margin 4.4%) down 44.9%, Sales Business Operating Income was ¥1.1B (prior ¥0.3B, margin 3.8%) up 262.6%. Consolidated operating margin after company-level costs fell to 2.5%. Non-operating items comprised non-operating income of ¥2.1B (including ¥0.6B FX gains) less non-operating expenses of ¥1.6B (interest expense ¥1.5B), resulting in Ordinary Income of ¥4.1B (YoY -34.5%). The recording of special gains of ¥8.8B produced Profit Before Tax of ¥12.9B; after corporate taxes of ¥5.6B and non-controlling interests of ¥1.6B, Net Income attributable to owners of the parent was ¥5.6B (published figure ¥7.2B is on a consolidated basis, YoY +82.6%). In conclusion, the company experienced revenue and operating decline (at the ordinary level), but achieved an increase in final profit due to a one-off special gain.
The Manufacturing Business (sales mix 80.4%) posted Revenue ¥112.4B (YoY -8.2%), Operating Income ¥5.0B (YoY -44.9%), Operating Margin 4.4%. Declining domestic market sales and rising manufacturing costs compressed margins and pressured consolidated operating income. The Sales Business (mix 20.5%) recorded Revenue ¥28.7B (YoY +15.2%), Operating Income ¥1.1B (YoY +262.6%), Operating Margin 3.8%. Expansion of sales to domestic and Singapore markets and improved profitability drove strong profit growth, but the segment remains small and its contribution to the group is limited. Other Businesses (mix 0.9%) had Revenue ¥1.3B (YoY +90.2%) and an operating loss of ¥0.0B (improved from -¥0.04B prior). Lease income and similar items grew but contributed little to profits. Total segment operating profit before corporate-level costs was ¥6.0B; after deducting corporate costs of ¥2.5B, consolidated Operating Income was ¥3.5B.
[Profitability] Operating margin 2.5% (down 2.3pt from 4.8%), Net margin 5.2% (up 2.5pt from 2.7%, boosted by special gains), Gross margin 21.0% (up 0.3pt), SG&A ratio 18.5% (up 2.6pt). ROE 3.6% (up 1.5pt from 2.1%, aided by higher Net Income from special gains), but leverage dependence is high (Total Assets/Equity 3.29x) and core earnings improvement is limited. Deterioration in operating-level profitability is evident, with SG&A increases absorbing gross margin improvement. [Cash Quality] Days Sales Outstanding (DSO) 231 days (improved from 244 days), Days Inventory Outstanding (DIO) 580 days (worsened from 486 days), Days Payable Outstanding (DPO) 127 days, yielding Cash Conversion Cycle (CCC) 684 days (up 81 days from 603 days) and lengthening materially. Inventory of ¥145.3B (22.0% of total assets) is notably stagnant, impairing working capital efficiency and cash generation. [Investment Efficiency] Total asset turnover 0.211x (annualized 0.844x), indicating weak asset-to-revenue conversion. [Financial Health] Equity Ratio 30.4% (prior 31.5%), D/E ratio 2.29x (interest-bearing debt ¥459.9B / shareholders' equity ¥201.1B) indicating high leverage, Interest Coverage 2.37x (Operating Income ¥3.5B / interest expense ¥1.5B) at a low level with limited buffer against interest burden. Cash and deposits ¥143.2B (21.7% of total assets) are secured, but short-term borrowings of ¥114.4B indicate high short-term dependence and refinancing risk. Goodwill of ¥60.9B (30.3% of equity) is high and carries future impairment risk.
Detailed Operating Cash Flow (OCF) disclosure was not provided, but balance sheet trends were analyzed to infer cash movements. Cash and deposits rose to ¥143.2B from ¥110.0B a year earlier (+¥33.1B), strengthening liquidity. Meanwhile, short-term borrowings increased materially to ¥114.4B (from ¥82.5B, +¥31.9B, +38.7%), suggesting concurrent increases in working capital demand and borrowing-based financing. Inventories increased to ¥145.3B (from ¥128.6B, +¥16.7B), extending DIO to 580 days. Trade receivables decreased to ¥88.4B (from ¥97.6B, -¥9.2B) and DSO shortened to 231 days. Trade payables fell to ¥38.5B (from ¥42.1B, -¥3.6B). Inventory buildup has strained working capital, seemingly necessitating short-term borrowings to cover liquidity. Long-term borrowings slightly declined to ¥167.5B (from ¥171.3B, -¥3.8B), but long-term borrowings due within one year increased to ¥72.2B (from ¥54.7B, +¥17.5B), raising refinancing needs. Interest paid rose to ¥1.5B (from ¥1.0B, +¥0.5B), increasing interest burden and, combined with low Interest Coverage, constraining free cash flow generation. The ¥8.8B special gain is non-recurring; assessing core cash conversion capability is essential.
Net Income of ¥7.2B (Net Income attributable to owners of the parent ¥5.6B) is heavily dependent on special gains of ¥8.8B and diverges from recurring earnings power. Of Profit Before Tax ¥12.9B, Operating Income ¥3.5B and Ordinary Income ¥4.1B represent recurring earnings, while special gains ¥8.8B (mainly compensation income ¥8.8B) were added as a one-off. Non-operating income ¥2.1B includes FX gains ¥0.6B and gains on sales of securities ¥0.7B, which are also somewhat non-recurring. Non-operating expenses ¥1.6B are largely interest expense ¥1.5B and represent a stable cost. Comprehensive income ¥8.5B is ¥1.3B higher than Net Income ¥7.2B after accounting for other comprehensive income including valuation differences on available-for-sale securities of -¥0.4B; divergence between comprehensive income and net income is small. On an accrual basis, DIO 580 days and inventory stagnation are notable, implying delayed cash conversion and potential impairment risk. Interest Coverage of 2.37x (Operating Income ¥3.5B vs. interest expense ¥1.5B) is low, indicating limited capacity to service interest from operating earnings.
Full Year guidance is unchanged: Revenue ¥575.0B (YoY flat), Operating Income ¥20.0B (YoY +27.5%), Ordinary Income ¥17.0B (YoY +0.5%), Net Income attributable to owners of the parent ¥14.0B. Q1 progress rates are: Revenue 24.3% (¥139.8B / ¥575.0B), broadly within the normal range (~25%), Operating Income 17.5% (¥3.5B / ¥20.0B) which is behind schedule (approx. -7.5pt vs. benchmark), and Net Income 39.8% (¥5.6B / ¥14.0B) which is ahead due to the special gain. Operating-level shortfall is material; improvement in profitability and SG&A efficiency from Q2 onward is a prerequisite for achieving full-year targets. The front-loading of Net Income is driven by non-recurring factors; restoring core earnings is the main challenge for the full year.
No dividend was paid by the end of Q1; payout ratio 0%. Full-year dividend forecast is also ¥0. Retained earnings stand at ¥81.0B, but given high D/E ratio of 2.29x, CCC of 684 days indicating heavy working capital burden, and low Interest Coverage of 2.37x, prioritizing internal reserves and restoring financial health is judged to be a rational capital allocation in the short term. No share buybacks have been executed.
Working capital efficiency risk: DIO 580 days and CCC 684 days have lengthened materially; inventory of ¥145.3B (22.0% of total assets) is notably stagnant. There is risk of inventory valuation losses and cash flow strain from working capital, making SKU optimization and stronger inventory control urgent.
Financial leverage risk: D/E ratio 2.29x and Interest Coverage 2.37x are low, creating vulnerability to rising interest rates or deteriorating refinancing conditions. High short-term borrowings of ¥114.4B and short-term liabilities dependence of 40.6% introduce maturity concentration and liquidity risk. Interest expense of ¥1.5B (up 50% YoY) is increasing the earnings burden; future interest rate moves will directly affect profitability and cash flows.
Segment concentration risk: The Manufacturing Business accounts for 80.4% of Revenue and the majority of Operating Income, so deterioration in that segment’s profitability (Operating Margin 4.4%, YoY -44.9%) heavily influences consolidated performance. Growth in the Sales Business (Revenue +15.2%, Operating Income +262.6%) is positive but small in scale, limiting diversification benefits. Goodwill of ¥60.9B (30.3% of equity) tied to M&A assets requires maintaining their profitability and carries impairment risk.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 2.5% | 5.2% (1.2%–6.4%) | -2.7pt |
| Net Margin | 5.2% | 3.7% (0.3%–4.9%) | +1.4pt |
Operating margin is -2.7pt below the industry median, indicating core earnings are below industry average. Net margin is +1.4pt above the median due to special gains, but sustainability is low.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (YoY) | -4.3% | 6.5% (3.8%–10.4%) | -10.8pt |
Revenue growth is -10.8pt below the industry median; while the industry is growing, the company experienced a decline, indicating challenges in market share capture and demand capture.
※ Source: Company compilation
Decline in core earnings is evident: Operating margin 2.5% (down 2.3pt from 4.8%) is well below the industry median of 5.2%. SG&A ratio rise to 18.5% (YoY +2.6pt) absorbed gross margin improvement, revealing negative operating leverage. Improving Manufacturing Business profitability and SG&A efficiency is key to achieving full-year Operating Income target of ¥20.0B, but Q1 progress of 17.5% vs. the benchmark is lagging and recovery from Q2 onward is essential.
Worsening working capital efficiency (CCC 684 days, DIO 580 days) is severely constraining cash generation. Inventory stagnation of ¥145.3B (22.0% of total assets) carries impairment risk, while the increase in short-term borrowings to ¥114.4B (YoY +38.7%) suggests delayed inventory reduction. Inventory optimization and faster accounts receivable collection to shorten CCC are urgent; success would materially improve free cash flow generation and financial health.
High financial leverage (D/E 2.29x) and low Interest Coverage (2.37x) increase vulnerability to interest burden; interest expense rise to ¥1.5B (YoY +50%) is pressuring earnings. Goodwill of ¥60.9B (30.3% of equity) is high, requiring verification of M&A asset profitability and monitoring for impairment risk. In the short term, strengthening internal reserves and improving working capital efficiency should be prioritized; dividends are suspended, but recovery in core earnings and capital efficiency could create shareholder return capacity in the future.
This report is an earnings analysis document automatically generated by AI analyzing XBRL earnings press release data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company based on public financial statements. Investment decisions should be made at your own responsibility and, if necessary, after consulting a professional advisor.